Literature DB >> 34371002

Younger patients with chronic limb threatening ischemia face more frequent amputations.

E Hope Weissler1, Cassie B Ford2, Manesh R Patel3, Phil Goodney4, Amy Clark2, Chandler Long5, W Schuyler Jones6.   

Abstract

INTRODUCTION: Amputations among younger patients with chronic limb threatening ischemia (CLTI) may carry higher personal and societal costs, but younger patients are often not included in CLTI research because of dataset limitations. We aimed to characterize and compare outcomes between younger (<65 years old) and older patients with CLTI.
METHODS: This retrospective cohort study identified patients with CLTI between July 1, 2014 and December 31, 2017 in the MarketScan commercial claims database, a proprietary set of claims for over 50 million patients with private insurance in the United States. The primary outcome was major adverse limb events (MALE); secondary outcomes included amputations, major adverse cardiovascular events, and statin prescription fills.
RESULTS: The study cohort included 64,663 people with CLTI, of whom 25,595 (39.6%) were <65 years old. Younger patients were more likely to have diabetes mellitus (54.1% versus 49.9%, P<.001) but less likely to have other comorbidities. A higher proportion of younger patients suffered MALE (31.7% versus 30.2%, P=.002), specifically amputation (11.5% versus 9.3%, P<.001). After adjustment, age <65 years old was associated with a 24% increased risk of amputation (HRadj 1.24, 95%CI 1.18-1.32, P<.001) and a 10% increased risk of MALE (HRadj 1.10, 95%CI 1.07-1.14, P<.001).
CONCLUSIONS: A significant proportion of commercially insured patients with CLTI are under the age of 65, and younger patients have worse limb-related outcomes. These findings highlight the importance of aggressively treating risk factors for atherosclerosis and intentionally including younger patients with CLTI in future analyses to better understand their disease patterns and outcomes.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34371002      PMCID: PMC8568640          DOI: 10.1016/j.ahj.2021.08.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  26 in total

1.  Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England.

Authors:  Meghan Dermody; Christopher Homsy; Yuanyuan Zhao; Philip P Goodney; James M Estes
Journal:  J Vasc Surg       Date:  2015-05-04       Impact factor: 4.268

2.  Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult U.S. Population.

Authors:  Linda S Geiss; Yanfeng Li; Israel Hora; Ann Albright; Deborah Rolka; Edward W Gregg
Journal:  Diabetes Care       Date:  2018-11-08       Impact factor: 19.112

3.  Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.

Authors:  Michael S Conte; Andrew W Bradbury; Philippe Kolh; John V White; Florian Dick; Robert Fitridge; Joseph L Mills; Jean-Baptiste Ricco; Kalkunte R Suresh; M Hassan Murad; Victor Aboyans; Murat Aksoy; Vlad-Adrian Alexandrescu; David Armstrong; Nobuyoshi Azuma; Jill Belch; Michel Bergoeing; Martin Bjorck; Nabil Chakfé; Stephen Cheng; Joseph Dawson; Eike S Debus; Andrew Dueck; Susan Duval; Hans H Eckstein; Roberto Ferraresi; Raghvinder Gambhir; Mauro Gargiulo; Patrick Geraghty; Steve Goode; Bruce Gray; Wei Guo; Prem C Gupta; Robert Hinchliffe; Prasad Jetty; Kimihiro Komori; Lawrence Lavery; Wei Liang; Robert Lookstein; Matthew Menard; Sanjay Misra; Tetsuro Miyata; Greg Moneta; Jose A Munoa Prado; Alberto Munoz; Juan E Paolini; Manesh Patel; Frank Pomposelli; Richard Powell; Peter Robless; Lee Rogers; Andres Schanzer; Peter Schneider; Spence Taylor; Melina V De Ceniga; Martin Veller; Frank Vermassen; Jinsong Wang; Shenming Wang
Journal:  Eur J Vasc Endovasc Surg       Date:  2019-06-08       Impact factor: 7.069

4.  Trends in Rates of Lower Extremity Amputation Among Patients With End-stage Renal Disease Who Receive Dialysis.

Authors:  Douglas Franz; Yuanchao Zheng; Nicholas J Leeper; Venita Chandra; Maria Montez-Rath; Tara I Chang
Journal:  JAMA Intern Med       Date:  2018-08-01       Impact factor: 21.873

5.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

6.  Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008.

Authors:  W Schuyler Jones; Manesh R Patel; David Dai; Sumeet Subherwal; Judith Stafford; Sarah Calhoun; Eric D Peterson
Journal:  J Am Coll Cardiol       Date:  2012-10-24       Impact factor: 24.094

7.  Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease.

Authors:  Shipra Arya; Anjali Khakharia; Zachary O Binney; Randall R DeMartino; Luke P Brewster; Philip P Goodney; Peter W F Wilson
Journal:  Circulation       Date:  2018-01-12       Impact factor: 29.690

8.  Population-based study of mortality and major amputation following lower limb revascularization.

Authors:  K Heikkila; I M Loftus; D C Mitchell; A S Johal; S Waton; D A Cromwell
Journal:  Br J Surg       Date:  2018-04-25       Impact factor: 6.939

9.  Frequency of Care and Mortality Following an Incident Diagnosis of Peripheral Artery Disease in the Inpatient or Outpatient Setting: The ARIC (Atherosclerosis Risk in Communities) Study.

Authors:  Corey A Kalbaugh; Laura Loehr; Lisa Wruck; Jennifer L Lund; Kunihiro Matsushita; Lindsay G S Bengtson; Gerardo Heiss; Anna Kucharska-Newton
Journal:  J Am Heart Assoc       Date:  2018-04-13       Impact factor: 5.501

10.  Billing code algorithms to identify cases of peripheral artery disease from administrative data.

Authors:  Jin Fan; Adelaide M Arruda-Olson; Cynthia L Leibson; Carin Smith; Guanghui Liu; Kent R Bailey; Iftikhar J Kullo
Journal:  J Am Med Inform Assoc       Date:  2013-10-28       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.